Approaches to the development of pharmacological interventions in multiple sclerosis
Davis, F.A.; Schauf, C.L.
Advances in Neurology 31: 505-510
1981
ISSN/ISBN: 0091-3952 PMID: 6275674 Document Number: 178348
Document emailed within 1 workday
Related Documents
Abad, P.; Nogales-Gaete, J.; Rivera, V.; Cristiano, E.; Hamuy, F.; Oehninger, C.; Alvarenga, R.M.P.; Tenembaum, S.; Alarcón-A, T.; Alarcón-G, T.; Cárcamo, C.; Córdova, M.; Díaz, V.; Erazo, R.; Espinosa, E.; Fernández, O.; Garcea, O.; García-Bonitto, J.; Gómez, A.; González-Rabelino, G.; Gracia, F.; Guillén, F.; Hernández, F.; Kleinsteuber, K.; Leiva-Fariñas, R.; León, S.; Macías, M.A.; Narváez, B.; Núñez-Orozco, L.; Paredes, V.; Peña, J.; Peralta, S.; Román, M.; Rubio, E.; Schlatter-Vieira, A.; Soto, A.; Tejada, M.E.; Vélez-Moncada, E. 2012: LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants Revista de Neurologia 55(12): 737-748Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Men'shikova, T.V.; Gerasimova, M.M.; Sliusar', N.N. 2000: A role of phosphoinositides in the development of multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 100(11): 52-53
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Sánchez-Chaparro, M.M.; Rodríguez-Sánchez, I.P.; Barrera-Saldaña, H.A.; Martínez-Villarreal, L.E.; Resendez-Pérez, D.; Gámez-Escobedo, I.A. 2015: MicroRNAs and their neuroimmunoregulator mechanisms in multiple sclerosis. Development of biomarkers for diagnosis Revista de Neurologia 60(12): 562-571
Cazzullo, C.L.; Montanini, R.; Ghezzi, A.; Zaffaroni, M.; Giussani, D.; Loner, R.; Caputo, D.; Marforio, S.; Zibetti, A. 1984: Clinical, immunologic and electrophysiologic correlations in evaluating multiple sclerosis in relation to its development Minerva Medica 75(43): 2585-2589
Mustafina, O.E.; Mikhaĭlova, A.M.; Bakhtiiarova, K.Z.; Nasibulin, T.R.; Tuktarova, I.A.; Makarycheva, O.I.; Sudomoina, M.A.; Boĭko, A.N.; Voronchikhina, S.A.; Volkova, L.I.; Magzhanov, R.V.; Favorova, O.O. 2008: Polymorphism of APOE gene and risk of development of the multiple sclerosis at ethnic Russians Molekuliarnaia Biologiia 42(6): 957-964
Cendrowski, W. 1991: The risk of multiple sclerosis development in patients with idiopathic optic neuritis: prognosis and other problems Neurologia i Neurochirurgia Polska 25(1): 87-93
Schergna, E.; Tonin, P. 1980: Development of multiple sclerosis with ocular onset as compared with other onset forms Rivista di Neurologia 50(6): 415-424
Popova, E.V.; Bryukhov, V.V.; Boyko, A.N.; Krotenkova, M.V.; Konovalova, O.E.; Sharanova, S.N. 2017: Atypical multiple sclerosis - Balo's concentric sclerosis: two case-reports and a review Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 117(2. Vyp. 2): 50-53
Stepień, M.; Cendrowski, W. 1974: Form of systemic lupus erythematosus (lupoid sclerosis) resembling multiple sclerosis Neurologia i Neurochirurgia Polska 8(4): 607-609
Alonso, K.; Medenica, R. 1995: Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders Journal of the National Medical Association 87(8): 561-568
Weber, Y.B.; Rupp, R.; Shane, H. 1994: Stabilizing suspension procedure involving multiple tendon transfers in a patient with multiple sclerosis Journal of Foot and Ankle Surgery: Official Publication of the American College of Foot and Ankle Surgeons 33(5): 430-437
Ferrante, L.; Mastronardi, L.; Bardella, L. 1986: Acute cerebral multiple sclerosis: importance of a multiple diagnostic approach. Clinical case Rivista di Neurologia 56(6): 347-357
Nabavi, S.M.; Hamzehloo, A.; Sabet, Z. 2011: Down syndrome presenting with multiple sclerosis, thyroid dysfunction, and diabetes mellitus. Multiple autoimmune disorders in a genetic disorder Neurosciences 16(4): 375-377
Kukes, V.G.; Shikh, E.V. 1995: Clinico-pharmacological approaches to the use of lasix Anesteziologiia i Reanimatologiia 5: 40-44
Borison, R.L.; Ang, L.; Chang, S.; Dysken, M.; Comaty, J.E.; Davis, J.M. 1982: New pharmacological approaches in the treatment of Tourette syndrome Advances in Neurology 35: 377-382